KCRS20 Abstracts

Modeling Spatial Ecology in Clear Cell Renal Cell Carcinoma Model: A Novel Tool to Support Drug Sequencing Decisions (Brandon Manley)

Host Immune Signatures as Therapy Response Biomarkers in Metastatic Renal Cell Carcinoma (Toni Choueiri)

Deciphering the Role of EGFR Splice Variants and Tumor-Immune Microenvironment in Renal Cell Carcinoma (Brandon Manley)

Characterizing and Targeting the Microenvironmental Barriers to Immunotherapeutic Response in Renal Cell Carcinoma (Abraham Hakimi)

Characterizing and Targeting the Microenvironmental Barriers to Immunotherapeutic Response in Renal Cell Carcinoma (Timothy Chan)

Noninvasive Diagnostic Assessment of Kidney Cancer Using Hyperpolarized 13C L-Tryptophan (Lloyd Lumata)

First Functional Analysis of an Inherited SETD2 Mutation Associated with Renal Cell Carcinoma (Rebecca Arnold)

The Pathogenesis and Therapy of Chromophobe Renal Cell Carcinoma: A Single-Cell RNA Sequencing Approach (Elizabeth Henske)

Unlocking the Human Relevance of a New Genetic Papillary Renal Cell Carcinoma Mouse Model (Richard Link)

Biological Determinants of Kidney Cancer Health Disparities (Khadijah Mitchell)

Therapeutic Targeting of Cystine Addiction of Renal Cell Carcinoma (Jen Tsan Chi)

Genomic and Functional Analysis of Translocation Renal Cell Carcinoma (Srinivas Viswanathan)

Studying BAP1 in Regulating Glucose Dependency in Renal Cancer: Mechanisms and Preclinical Translation (Boyi Gan)

Personalized T-Cell Immunotherapy for Renal Cell Carcinoma (Shreeram Akilesh)

Personalized T-Cell Immunotherapy for Renal Cell Carcinoma (Scott Tykodi)

Defining the Role of Beta-Catenin Activation in Wilms Tumor (Keri Drake)

TBK1 Serves as a Novel Therapeutic Target in Kidney Cancers with VHL Loss (Qing Zhang)

Endogenous Retrovirus Expression, Chromatin Abnormalities, and Response to Immune Checkpoint Blockade in Clear Cell Renal Cell Cancer (Shridar Ganesan)

Targeting IGF1R Signaling in MTAP-Deficient Kidney Cancer (Ching-Hsien Chen)

Oncolytic Single-Cycle Replicating Immunotherapies for Kidney Cancer (Michael Barry)

Development and Testing of Circulating-Free Methylation DNA as a Prognostic Biomarker for Recurrent Kidney Cancer (Toni Choueiri)

Immune Checkpoint Targeted Immuno-PET to Identify Therapy-Induced Adaptive Resistance (Raquibul Hannan)

Immune Checkpoint Targeted Immuno-PET to Identify Therapy-Induced Adaptive Resistance (Xiankai Sun)

Molecular Characterization and Therapeutic Targeting of TFE3 Fusion Kidney Cancers (Emily Cheng)

Therapeutic Targeting of FLCN-Deficient Renal Cancers (Othon Iliopoulos)

Profilin 1 as a Novel Target in Patients with Renal Cancer (Partha Roy)

Targeted Pro-Inflammatory Prodrugs for the Immunotherapy of Kidney Cancer (Hans Hammers)

Functionally Characterizing the Enhancer Cistrome in Advanced Human Kidney Cancer (Mark Pomerantz)

Quantitative CT Biomarkers to Predict Metastatic RCC Response to Antiangiogenic Therapy (Andrew Smith)